Page last updated: 2024-10-28

gw8510 and Carcinoma, Epidermoid

gw8510 has been researched along with Carcinoma, Epidermoid in 1 studies

GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P1
Wu, JN1
Shu, Y1
Jiang, HG1
Zhao, XH1
Qian, H1
Chen, K1
Lan, T1
Chen, CG1
Li, J1

Other Studies

1 other study available for gw8510 and Carcinoma, Epidermoid

ArticleYear
Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.
    Clinical science (London, England : 1979), 2018, 07-16, Volume: 132, Issue:13

    Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Carcinoma, Squamous Cell; Deoxycytidine; Down-R

2018